Healing Paper Completes Attracting 42.8 Billion Won in Investment

Healing Paper, which operates the beauty medical platform 'Gangnam Unnie', announced on the 17th that it has completed attracting 42.8 billion won in Series C investment.

This Series C round was participated by major investment institutions such as Korea Investment Partners, Shinhan Venture Investment, KT Investment, IMM Investment, and Kiwoom Investment, and Premier Partners, Intervest, Aju IB Investment, and DSC Investment also joined as follow-up investors. In addition, Korea Investment Partners will participate in the board of directors for the first time through this investment.

With this investment, Gangnam Unni plans to accelerate its growth as a global beauty medical platform. Starting with Japan in 2019, Gangnam Unni began its overseas expansion in earnest, and is providing hospital reservation services for foreign patients visiting Korean hospitals and users visiting local hospitals in Japan. In November of last year, it launched the Thai version of 'Unni (UNNI)', expanding its business in Thailand.

In addition, Gangnam Unnie plans to expand its B2B solutions for aesthetic medicine hospitals. It will support hospitals to effectively manage and market their customers through B2B solutions specialized for aesthetic medicine hospitals, such as CRM software and photography equipment.

The investment firm that participated in this investment stated, “Gangnam Unnie is a team that seriously understands the problems that aesthetic medicine customers and hospitals are experiencing, and has the professional capabilities and experience to solve them,” and “We hope that Gangnam Unnie will grow into a platform that leads the global aesthetic medicine market, following its success in Korea and Japan.”

Hong Seung-il, CEO of Healing Paper, said, “Through this investment, Gangnam Unnie will further improve customer experience and take the lead with a greater sense of responsibility in solving the information imbalance problem in the global aesthetic medicine market.” He added, “We will do our best to promote Korea’s aesthetic medicine competitiveness to the world and contribute to the growth of the aesthetic medicine industry.”


  • See more related articles